Since higher T stage reflects greater tumor size and invasion, this trend supports the idea that CSF2 may contribute to tumor aggressiveness, perhaps by influencing cell proliferation or extracellular matrix remodeling. The gene discussed is CSF2; the disease is neoplasm.